“…At the hepatic level, activated PPAR‐α enhances lipolysis, mitochondrial β‐oxidation of FAs, and TAG storage, while reducing lipogenesis . Although PPAR‐α activation is accomplished by FAs such as docosahexaenoic acid (DHA; C22:6 n‐3), there is no clear evidence showing this property for EVOO, a product that is capable of upregulating Nrf‐2 signaling in other experimental models . According to these backgrounds, the aim of this work was to test the influence of a combination of low doses of DHA and EVOO supplementation on the activation level of transcription factors PPAR‐α, Nrf2, NF‐κB, and SREBP‐1c, in relation to the attenuation of liver (i) steatosis, (ii) pro‐inflammation, (iii) oxidative stress, (iv) pro‐lipogenic status, and (v) preservation of n‐3 long‐chain PUFAs (LCPUFA) content altered in HFD‐fed mice.…”